Release Date: 02/07/10 10:29 Summary: Appointment of One Investment Group Price Sensitive: Yes Download Document 32.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%